Name | Number of supported studies | Average coverage | |
---|---|---|---|
respiratory goblet cell | 7 studies | 26% ± 8% | |
renal alpha-intercalated cell | 7 studies | 61% ± 12% | |
type II pneumocyte | 6 studies | 23% ± 6% | |
epithelial cell | 6 studies | 32% ± 12% | |
ionocyte | 6 studies | 68% ± 22% | |
kidney loop of Henle epithelial cell | 6 studies | 44% ± 17% | |
club cell | 6 studies | 21% ± 4% | |
kidney distal convoluted tubule epithelial cell | 5 studies | 47% ± 7% | |
basal cell | 4 studies | 25% ± 5% | |
duct epithelial cell | 4 studies | 39% ± 13% | |
renal principal cell | 4 studies | 40% ± 7% | |
brush cell | 3 studies | 30% ± 8% | |
epithelial cell of proximal tubule | 3 studies | 33% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 4 studies | 39% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 80% | 6956.31 | 197 / 245 | 70% | 11.71 | 353 / 502 |
stomach | 72% | 5526.20 | 260 / 359 | 78% | 18.11 | 223 / 286 |
kidney | 100% | 20026.31 | 89 / 89 | 50% | 25.72 | 448 / 901 |
thymus | 100% | 19564.66 | 650 / 653 | 43% | 10.51 | 260 / 605 |
lung | 55% | 2741.34 | 317 / 578 | 78% | 17.56 | 904 / 1155 |
breast | 67% | 6558.80 | 306 / 459 | 64% | 16.80 | 711 / 1118 |
esophagus | 38% | 2155.27 | 545 / 1445 | 91% | 26.22 | 166 / 183 |
pancreas | 40% | 660.15 | 130 / 328 | 85% | 16.34 | 152 / 178 |
intestine | 38% | 4106.99 | 369 / 966 | 86% | 20.33 | 452 / 527 |
skin | 71% | 9980.32 | 1290 / 1809 | 15% | 1.98 | 71 / 472 |
bladder | 29% | 768.05 | 6 / 21 | 57% | 12.09 | 288 / 504 |
tonsil | 0% | 0 | 0 / 0 | 69% | 12.62 | 31 / 45 |
uterus | 4% | 252.36 | 7 / 170 | 63% | 15.94 | 289 / 459 |
ovary | 0% | 0 | 0 / 180 | 41% | 5.13 | 178 / 430 |
spleen | 25% | 384.61 | 60 / 241 | 0% | 0 | 0 / 0 |
brain | 2% | 29.57 | 47 / 2642 | 20% | 3.68 | 141 / 705 |
muscle | 21% | 526.18 | 172 / 803 | 0% | 0 | 0 / 0 |
adipose | 16% | 469.90 | 187 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 6.12 | 1 / 226 | 7% | 1.03 | 29 / 406 |
adrenal gland | 0% | 31.72 | 1 / 258 | 4% | 0.55 | 10 / 230 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.19 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.12 | 2 / 80 |
blood vessel | 1% | 9.95 | 8 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 2.55 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002070 | Biological process | epithelial cell maturation |
GO_0000902 | Biological process | cell morphogenesis |
GO_0008340 | Biological process | determination of adult lifespan |
GO_0045927 | Biological process | positive regulation of growth |
GO_0007431 | Biological process | salivary gland development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007028 | Biological process | cytoplasm organization |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | TFCP2L1 |
Protein name | Transcription factor CP2-like protein 1 (CP2-related transcriptional repressor 1) (CRTR-1) (Transcription factor LBP-9) |
Synonyms | CRTR1 LBP9 |
Description | FUNCTION: Transcription factor that facilitates establishment and maintenance of pluripotency in embryonic stem cells (ESCs) . With KLF2, acts as the major effector of self-renewal that mediates induction of pluripotency downstream of LIF/STAT3 and Wnt/beta-catenin signaling (By similarity). Required for normal duct development in the salivary gland and kidney (By similarity). Coordinates the development of the kidney collecting ducts intercalated (IC) and principal (PC) cells, which regulate acid-base and salt-water homeostasis, respectively (By similarity). Regulates the expression of IC genes including subunits B1 and D2 of the V-ATPase complex, OXGR1, CA12, SLC4A1, AQP6 and IC-specific transcription factor FOXI1 (By similarity). Regulates also the expression of JAG1 and subsequent notch signaling in the collecting duct (By similarity). JAG1 initiates notch signaling in PCs but inhibits notch signaling in ICs (By similarity). Acts as a transcriptional suppressor that may suppress UBP1-mediated transcriptional activation (By similarity). Modulates the placental expression of CYP11A1 . . |
Accessions | ENST00000263707.6 Q9NZI6 |